5/19/2014 6:56:15 AM
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Jefferies 2014 Global Healthcare Conference in New York on Monday, June 2, 2014 at 1:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by